Parenteral Drugs India has received an approval for disinvestment of equity shares held by the company in its non-operational subsidiary companies. The board of directors at their meeting held on December 30, 2015 has approved for the same.
The company has received approval for disinvestment of equity shares held in Parentech Healthcare and Parenteral Surgicals as the same are loss making companies, and accorded its in-principle approval to declare the non-working subsidiaries of the company - Abhay Drugs, Anjaney Pharmaceuticals, Parenteral Biotech and Parenteral Impex as defunct company as there is no business in these subsidiary companies.
Parenteral Drugs (India) (PDIL) is a manufacturer of Intravenous Fluid (IVF), one of the basic pharmaceutical compounds.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: